UBS Maintains Buy on Universal Health Servs, Raises Price Target to $267
Portfolio Pulse from Benzinga Newsdesk
UBS analyst A.J. Rice maintains a Buy rating on Universal Health Services (NYSE:UHS) and raises the price target from $247 to $267.
August 14, 2024 | 1:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UBS analyst A.J. Rice maintains a Buy rating on Universal Health Services and raises the price target from $247 to $267.
The Buy rating and increased price target from a reputable analyst at UBS is likely to positively influence investor sentiment and drive short-term price appreciation for UHS.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100